미국의 형광 현미경 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 용도별, 지역별, 부문별 예측(2026-2033년)

U.S. Fluorescence Microscopy Market Summary

The U.S. fluorescence microscopy market size was estimated at USD 198.7 million in 2025 and is expected to reach USD 386.4 million by 2033, growing at a CAGR of 8.8% from 2026 to 2033. Key market drivers include investments in biomedical research, increasing adoption of advanced imaging technologies in life sciences, and rising demand for high-resolution cellular and molecular analysis.

Significant funding from organizations such as the National Institutes of Health has accelerated research in areas including cancer biology, neuroscience, immunology, and drug discovery, all of which rely heavily on fluorescence imaging techniques.

Expansion in Life Sciences & Biomedical Research

The U.S. has one of the world's strongest research ecosystems, supported by substantial funding from federal agencies such as the National Institutes of Health (NIH), the National Science Foundation (NSF), and the Department of Defense, as well as investments from academic medical centers, biotechnology firms, and pharmaceutical companies.

As research in cellular biology, genomics, proteomics, immunology, and neuroscience becomes more complex and data-intensive, the need for high-resolution, multi-color, and live-cell imaging systems continues to rise. Furthermore, the growing emphasis on precision medicine, translational research, and early disease detection strengthens the reliance on fluorescence-based imaging technologies, thereby driving consistent market growth in the U.S.

For instance, the EVOS imaging systems from Thermo Fisher Scientific (Invitrogen brand) are designed to simplify microscopy workflows while delivering high-performance fluorescence imaging across applications ranging from routine cell culture monitoring to complex spatial tissue analysis. The EVOS portfolio includes digital fluorescence microscopes such as the M3000, M5000, and M7000, which enable brightfield, phase-contrast, multi-color fluorescence, and automated 2D/3D imaging, as well as the S1000 spatial imaging system with multiplex spectral capabilities for studying cellular interactions within tissues. Such innovations demonstrate how increasing research complexity in fields such as cellular biology, immunology, and translational medicine is driving demand for high-resolution, automated, and quantitative fluorescence microscopy solutions, thereby reinforcing market growth in the U.S. research ecosystem.

U.S. Fluorescence Microscopy Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. fluorescence microscopy market report based on type, application, and region:

• Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Upright Fluorescence Microscopy
  • Inverted Fluorescence Microscopy
• Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Life Science
  • Material Science
  • Semiconductors
  • Nanotechnology
  • Other Applications
• Region Outlook (Revenue, USD Million, 2021 - 2033)
  • West
  • Southwest
  • Southeast
  • Midwest
  • Northeast

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment Definitions
• 1.2. Estimates and Forecast Timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
  • 1.4.5. Details of Primary Research
  • 1.4.6. Research Assumption
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Data Visualization
• 1.7. Model Details
  • 1.7.1. Volume Price Analysis
• 1.8. Objectives
  • 1.8.1. Objective - 1
  • 1.8.2. Objective - 2
  • 1.8.3. Objective - 3
• 1.9. List of Secondary Sources
• 1.10. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. U.S. Fluorescence Microscopy Market
  • 2.1.1. Market Snapshot
  • 2.1.2. Segment Snapshot
  • 2.1.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Regulatory Framework
• 3.4. Business Environment Analysis Tools
  • 3.4.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis

Chapter 4. U.S. Fluorescence Microscopy Market: Type Estimates & Trend Analysis

• 4.1. U.S. Fluorescence Microscopy Market: Type Movement Analysis
• 4.2. U.S. Fluorescence Microscopy Market: Type Segment Dashboard
• 4.3. Type Movement & Market Share Analysis, 2025 & 2033
• 4.4. U.S. Fluorescence Microscopy Market Estimates & Forecast, by Type
• 4.5. Upright Fluorescence Microscopy
  • 4.5.1. Upright Fluorescence Microscopy Market, 2021 - 2033 (USD Million)
• 4.6. Inverted Fluorescence Microscopy
  • 4.6.1. Inverted Fluorescence Microscopy Market, 2021 - 2033 (USD Million)

Chapter 5. U.S. Fluorescence Microscopy Market: Application Estimates & Trend Analysis

• 5.1. U.S. Fluorescence Microscopy Market: Application Movement Analysis
• 5.2. U.S. Fluorescence Microscopy Market: Application Segment Dashboard
• 5.3. Application Movement & Market Share Analysis, 2025 & 2033
• 5.4. U.S. Fluorescence Microscopy Market Estimates & Forecast, by Application
• 5.5. Life Science
  • 5.5.1. Life Science Market, 2021 - 2033 (USD Million)
• 5.6. Material Science
  • 5.6.1. Material Science Market, 2021 - 2033 (USD Million)
• 5.7. Semiconductors
  • 5.7.1. Semiconductors Market, 2021 - 2033 (USD Million)
• 5.8. Nanotechnology
  • 5.8.1. Nanotechnology Market, 2021 - 2033 (USD Million)
• 5.9. Other Applications
  • 5.9.1. Other Applications Market, 2021 - 2033 (USD Million)

Chapter 6. U.S. Fluorescence Microscopy Market: Region Estimates & Trend Analysis

• 6.1. U.S. Fluorescence Microscopy Market: Region Movement Analysis
• 6.2. U.S. Fluorescence Microscopy Market: Region Segment Dashboard
• 6.3. Region Movement & Market Share Analysis, 2025 & 2033
• 6.4. U.S. Fluorescence Microscopy Market Estimates & Forecast, by Region
• 6.5. West
  • 6.5.1. West Market, 2021 - 2033 (USD Million)
• 6.6. Southeast
  • 6.6.1. Southeast Market, 2021 - 2033 (USD Million)
• 6.7. Southwest
  • 6.7.1. Southwest Market, 2021 - 2033 (USD Million)
• 6.8. Midwest
  • 6.8.1. Midwest Market, 2021 - 2033 (USD Million)
• 6.9. Northeast
  • 6.9.1. Northeast Market, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company Categorization
• 7.2. Company Market Position Analysis, 2025
• 7.3. Strategy Mapping
• 7.4. Company Profiles
  • 7.4.1. Zeiss Group
    • 7.4.1.1. Overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Bruker Corporation
    • 7.4.2.1. Overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Thermo Fisher Scientific, Inc.
    • 7.4.3.1. Overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Nikon Corporation
    • 7.4.4.1. Overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Olympus Corporation
    • 7.4.5.1. Overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Leica Microsystems
    • 7.4.6.1. Overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. KEYENCE CORPORATION
    • 7.4.7.1. Overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. ECHO
    • 7.4.8.1. Overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives